Baillie Gifford - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 132 filers reported holding BRIDGEBIO PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2022$4,969,000
+13.0%
499,889
+3.2%
0.01%0.0%
Q2 2022$4,399,000
-20.0%
484,477
-10.6%
0.01%
+25.0%
Q1 2022$5,500,000
-32.7%
541,891
+10.7%
0.00%0.0%
Q4 2021$8,169,000
-62.6%
489,721
+5.1%
0.00%
-63.6%
Q3 2021$21,835,000
-14.7%
465,876
+11.0%
0.01%
-8.3%
Q2 2021$25,597,000
+32.9%
419,892
+34.3%
0.01%
+9.1%
Q1 2021$19,259,000
+128.5%
312,645
+163.8%
0.01%
+120.0%
Q4 2020$8,429,000
+271.5%
118,532
+96.0%
0.01%
+150.0%
Q3 2020$2,269,000
+1100.5%
60,469
+941.0%
0.00%
Q2 2020$189,000
+142.3%
5,809
+115.1%
0.00%
Q1 2020$78,0002,7000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders